Work

What’s new and what’s next for vaccines in 2026?

Year: 2026

Type: article

Abstract: As the vaccines field continues to evolve, new technologies, targets, and delivery strategies are reshaping both research priorities and implementation pathways. We asked members of the Vaccine Insights Editorial Advisory Board to reflect on the areas shaping their current work and the developments they believe will influence the field in the years ahead. "Based on current trends, I expect increased focus on vaccine formulations that incorporate multiple antigens or immunogens, potentially addressing several diseases or stages within a single product." - Rajender Jena, Head Malaria Vaccines (Quality Control), Serum Institute of India Pvt Ltd, India

Source: Vaccine Insights

DOI: 10.18609/vac.2026.003

Authors: Trina Racine, Cleo Kontoravdi, Isis Kanevsky, Jeffrey Ulmer, Tuck Seng Wong, Christopher Ton, Rajender Jena, Pierre Morgon

Institutions: Vaccine and Infectious Disease Organization, Imperial College London, Pfizer (United States), University of Sheffield, Merck & Co., Inc., Rahway, NJ, USA (United States), Serum Institute of India (India)

Language: English

Topic: Immune responses and vaccinations

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W7128427545

FWCI:

Cites:

Cited by:

Related to: